Human growth hormone (GH) causes a variety of physiological and metabolic effects in humans and plays a pivotal role in postnatal growth. In somatotroph cells of the anterior pituitary, GH is stored in concentrated forms in secretory granules to be rapidly released upon GH-releasing hormone stimulation. During the process of secretory granule biogenesis, self-association of GH occurs in the compartments of the early secretory pathway (endoplasmic reticulum and Golgi complex). Since this process is greatly facilitated by the presence of zinc ions, it is of importance to understand the potential role of zinc transporters that participate in the fine-tuning of zinc homeostasis and dynamics, particularly in the early secretory pathway. Thus, the role of zinc transporters in supplying the secretory pathway with the sufficient amount of zinc required for the biogenesis of GH-containing secretory granules is essential for normal secretion. This report, illustrated by a clinical case report on transient neonatal zinc deficiency, focuses on the role of zinc in GH storage in the secretory granules and highlights the role of specific zinc transporters in the early secretory pathway.

Keywords:
Growth hormone, Secretory pathway, Zinc, Zinc deficiency, Growth impairment
1.
Meinhardt UJ, Ho KK: Modulation of growth hormone action by sex steroids. Clin Endocrinol (Oxf) 2006;65:413-422.
2.
Norrelund H: The metabolic role of growth hormone in humans with particular reference to fasting. Growth Horm IGF Res 2005;15:95-122.
3.
Van Cauter E, Latta F, Nedeltcheva A, Spiegel K, Leproult R, Vandenbril C, Weiss R, Mockel J, Legros JJ, Copinschi G: Reciprocal interactions between the GH axis and sleep. Growth Horm IGF Res 2004;14(suppl A):S10-S17.
4.
Widdowson WM, Healy ML, Sonksen PH, Gibney J: The physiology of growth hormone and sport. Growth Horm IGF Res 2009;19:308-319.
5.
Dannies PS: Mechanisms for storage of prolactin and growth hormone in secretory granules. Mol Genet Metab 2002;76:6-13.
6.
Tooze SA, Martens GJ, Huttner WB: Secretory granule biogenesis: rafting to the snare. Trends Cell Biol 2001;11:116-122.
7.
Muller EE, Locatelli V, Cocchi D: Neuroendocrine control of growth hormone secretion. Physiol Rev 1999;79:511-607.
8.
Herrington J, Carter-Su C: Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab 2001;12:252-257.
9.
MacDonald RS: The role of zinc in growth and cell proliferation. J Nutr 2000;130:1500S-1508S.
10.
Fraker PJ, King LE, Laakko T, Vollmer TL: The dynamic link between the integrity of the immune system and zinc status. J Nutr 2000;130:1399S-1406S.
11.
Apgar J: Effect of zinc deficiency on parturition in the rat. Am J Physiol 1968;215:160-163.
12.
Hurley LS, Mutch PB: Prenatal and postnatal development after transitory gestational zinc deficiency in rats. J Nutr 1973;103:649-656.
13.
Lichten LA, Cousins RJ: Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr 2009;29:153-176.
14.
Sekler I, Sensi SL, Hershfinkel M, Silverman WF: Mechanism and regulation of cellular zinc transport. Mol Med 2007;13:337-343.
15.
Thorlacius-Ussing O: Zinc in the anterior pituitary of rat: a histochemical and analytical work. Neuroendocrinology 1987;45:233-242.
16.
Dannies PS: Prolactin and growth hormone aggregates in secretory granules: the need to understand the structure of the aggregate. Endocr Rev 2012;33:254-270.
17.
Dorea JG: Zinc deficiency in nursing infants. J Am Coll Nutr 2002;21:84-87.
18.
Aggett PJ, Atherton DJ, More J, Davey J, Delves HT, Harries JT: Symptomatic zinc deficiency in a breast-fed preterm infant. Arch Dis Child 1980;55:547-550.
19.
Parker PH, Helinek GL, Meneely RL, Stroop S, Ghishan FK, Greene HL: Zinc deficiency in a premature infant fed exclusively human milk. Am J Dis Child 1982;136:77-78.
20.
Zimmerman AW, Hambidge KM, Lepow ML, Greenberg RD, Stover ML, Casey CE: Acrodermatitis in breast-fed premature infants: evidence for a defect of mammary zinc secretion. Pediatrics 1982;69:176-183.
21.
Chowanadisai W, Lonnerdal B, Kelleher SL: Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency. J Biol Chem 2006;281:39699-39707.
22.
Lasry I, Seo YA, Ityel H, Shalva N, Pode-Shakked B, Glaser F, Berman B, Berezovsky I, Goncearenco A, Klar A, Levy J, Anikster Y, Kelleher SL, Assaraf YG: A dominant negative heterozygous G87R mutation in the zinc transporter, ZnT-2 (SLC30A2), results in transient neonatal zinc deficiency. J Biol Chem 2012;287:29348-29361.
23.
Schmitt S, Kury S, Giraud M, Dreno B, Kharfi M, Bezieau S: An update on mutations of the SLC39A4 gene in acrodermatitis enteropathica. Hum Mutat 2009;30:926-933.
24.
Prader A, Largo RH, Molinari L, Issler C: Physical growth of Swiss children from birth to 20 years of age. Helv Paediatr Acta 1989;52(suppl):1-125.
25.
Horan M, Millar DS, Hedderich J, Lewis G, Newsway V, Mo N, Fryklund L, Procter AM, Krawczak M, Cooper DN: Human growth hormone 1 (GH1) gene expression: complex haplotype-dependent influence of polymorphic variation in the proximal promoter and locus control region. Hum Mutat 2003;21:408-423.
26.
Baumann G: Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr Rev 1991;12:424-449.
27.
Lewis UJ, Bonewald LF, Lewis LJ: The 20,000-dalton variant of human growth hormone: location of the amino acid deletions. Biochem Biophys Res Commun 1980;92:511.
28.
Binder G, Ranke MB: Screening for growth hormone (GH) gene splice-site mutations in sporadic cases with severe isolated GH deficiency using ectopic transcript analysis. J Clin Endocrinol Metab 1995;80:1247-1252.
29.
Anelli T, Sitia R: Protein quality control in the early secretory pathway. EMBO J 2008;27:315-327.
30.
Losev E, Reinke CA, Jellen J, Strongin DE, Bevis BJ, Glick BS: Golgi maturation visualized in living yeast. Nature 2006;441:1002-1006.
31.
Nakano A, Luini A: Passage through the Golgi. Curr Opin Cell Biol 2010;22:471-478.
32.
Puthenveedu MA, Linstedt AD: Subcompartmentalizing the Golgi apparatus. Curr Opin Cell Biol 2005;17:369-375.
33.
De Matteis MA, Luini A: Exiting the Golgi complex. Nat Rev Mol Cell Biol 2008;9:273-284.
34.
Glombik MM, Gerdes HH: Signal-mediated sorting of neuropeptides and prohormones: secretory granule biogenesis revisited. Biochimie 2000;82:315-326.
35.
Wu MM, Grabe M, Adams S, Tsien RY, Moore HP, Machen TE: Mechanisms of pH regulation in the regulated secretory pathway. J Biol Chem 2001;276:33027-33035.
36.
Sankoorikal BJ, Zhu YL, Hodsdon ME, Lolis E, Dannies PS: Aggregation of human wild-type and H27A-prolactin in cells and in solution: Roles of Zn2+, Cu2+, and pH. Endocrinology 2002;143:1302-1309.
37.
Cunningham BC, Mulkerrin MG, Wells JA: Dimerization of human growth hormone by zinc. Science 1991;253:545-548.
38.
Iliev DI, Wittekindt NE, Ranke MB, Binder G: In vitro analysis of hGH secretion in the presence of mutations of amino acids involved in zinc binding. J Mol Endocrinol 2007;39:163-167.
39.
Lee MS, Zhu YL, Chang JE, Dannies PS: Acquisition of Lubrol insolubility, a common step for growth hormone and prolactin in the secretory pathway of neuroendocrine cells. J Biol Chem 2001;276:715-721.
40.
Sun Z, Li PS, Dannies PS, Lee JC: Properties of human prolactin (PRL) and H27A-PRL, a mutant that does not bind Zn++. Mol Endocrinol 1996;10:265-271.
41.
Miura T, Suzuki K, Kohata N, Takeuchi H: Metal binding modes of Alzheimer's amyloid β-peptide in insoluble aggregates and soluble complexes. Biochemistry 2000;39:7024-7031.
42.
Vembar SS, Brodsky JL: One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol 2008;9:944-957.
43.
Berg JM, Shi Y: The galvanization of biology: a growing appreciation for the roles of zinc. Science 1996;271:1081-1085.
44.
Huang L, Kirschke CP, Gitschier J: Functional characterization of a novel mammalian zinc transporter, ZnT6. J Biol Chem 2002;277:26389-26395.
45.
Kambe T, Narita H, Yamaguchi-Iwai Y, Hirose J, Amano T, Sugiura N, Sasaki R, Mori K, Iwanaga T, Nagao M: Cloning and characterization of a novel mammalian zinc transporter, zinc transporter 5, abundantly expressed in pancreatic beta cells. J Biol Chem 2002;277:19049-19055.
46.
Kirschke CP, Huang L: ZnT7, a novel mammalian zinc transporter, accumulates zinc in the Golgi apparatus. J Biol Chem 2003;278:4096-4102.
47.
Suzuki T, Ishihara K, Migaki H, Nagao M, Yamaguchi-Iwai Y, Kambe T: Two different zinc transport complexes of cation diffusion facilitator proteins localized in the secretory pathway operate to activate alkaline phosphatases in vertebrate cells. J Biol Chem 2005;280:30956-30962.
48.
Ishihara K, Yamazaki T, Ishida Y, Suzuki T, Oda K, Nagao M, Yamaguchi-Iwai Y, Kambe T: Zinc transport complexes contribute to the homeostatic maintenance of secretory pathway function in vertebrate cells. J Biol Chem 2006;281:17743-17750.
49.
Suzuki T, Ishihara K, Migaki H, Matsuura W, Kohda A, Okumura K, Nagao M, Yamaguchi-Iwai Y, Kambe T: Zinc transporters, ZnT5 and ZnT7, are required for the activation of alkaline phosphatases, zinc-requiring enzymes that are glycosylphosphatidylinositol-anchored to the cytoplasmic membrane. J Biol Chem 2005;280:637-643.
50.
Ohana E, Hoch E, Keasar C, Kambe T, Yifrach O, Hershfinkel M, Sekler I: Identification of the Zn2+ binding site and mode of operation of a mammalian Zn2+ transporter. J Biol Chem 2009;284:17677-17686.
51.
Inoue K, Matsuda K, Itoh M, Kawaguchi H, Tomoike H, Aoyagi T, Nagai R, Hori M, Nakamura Y, Tanaka T: Osteopenia and male-specific sudden cardiac death in mice lacking a zinc transporter gene, ZnT5. Hum Mol Genet 2002;11:1775-1784.
52.
Magoulas C, McGuinness L, Balthasar N, Carmignac DF, Sesay AK, Mathers KE, Christian H, Candeil L, Bonnefont X, Mollard P, Robinson IC: A secreted fluorescent reporter targeted to pituitary growth hormone cells in transgenic mice. Endocrinology 2000;141:4681-4689.
53.
McGuinness L, Magoulas C, Sesay AK, Mathers K, Carmignac D, Manneville JB, Christian H, Phillips JA 3rd, Robinson IC: Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice. Endocrinology 2003;144:720-731.
54.
Kawakami N, Sakane N, Nishizawa F, Iwao M, Fukada SI, Tsujikawa K, Kohama Y, Ikawa M, Okabe M, Yamamoto H: Green fluorescent protein-transgenic mice: immune functions and their application to studies of lymphocyte development. Immunol Lett 1999;70:165-171.
55.
Fukada T, Civic N, Furuichi T, Shimoda S, Mishima K, Higashiyama H, Idaira Y, Asada Y, Kitamura H, Yamasaki S, Hojyo S, Nakayama M, Ohara O, Koseki H, Dos Santos HG, Bonafe L, Ha-Vinh R, Zankl A, Unger S, Kraenzlin ME, Beckmann JS, Saito I, Rivolta C, Ikegawa S, Superti-Furga A, Hirano T: The zinc transporter SLC39A13/Zip13 is required for connective tissue development; its involvement in BMP/TGF-β signaling pathways. PLoS One 2008;3:e3642.
56.
Huang L, Kirschke CP, Zhang Y, Yu YY: The Zip7 gene (SLC39A7) encodes a zinc transporter involved in zinc homeostasis of the Golgi apparatus. J Biol Chem 2005;280:15456-15463.
57.
Matsuura W, Yamazaki T, Yamaguchi-Iwai Y, Masuda S, Nagao M, Andrews GK, Kambe T: SLC39A9 (Zip9) regulates zinc homeostasis in the secretory pathway: characterization of the Zip subfamily I protein in vertebrate cells. Biosci Biotechnol Biochem 2009;73:1142-1148.
58.
Hojyo S, Fukada T, Shimoda S, Ohashi W, Bin BH, Koseki H, Hirano T: The zinc transporter SLC39A14/Zip14 controls G-protein coupled receptor-mediated signaling required for systemic growth. PLoS One 2011;6:e18059.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.